MGX (Metagenomi Therapeutics) Float Percentage Of Total Shares Outstanding: 81.03% (As of Jul. 05, 2026)


MGX Metagenomi Therapeutics Inc MGX
10 GF Score
Price $1.26
! 4 Warning Signs
View Full Analysis

What is Metagenomi Therapeutics Float Percentage Of Total Shares Outstanding?

Metagenomi Therapeutics MGX +4.13% 10 Float Percentage Of Total Shares Outstanding is 81.03% as of Jul. 05, 2026. GuruFocus rates MGX with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Metagenomi Therapeutics's float shares is 30.51 Mil. Metagenomi Therapeutics's total shares outstanding is 37.65 Mil. Metagenomi Therapeutics's float percentage of total shares outstanding is 81.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Metagenomi Therapeutics's Insider Ownership is 11.80%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Metagenomi Therapeutics's Institutional Ownership is 20.54%.

MGX
10GF Score
Metagenomi Therapeutics Inc MGX
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metagenomi Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Metagenomi Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=30.51/37.65
=81.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 81.03% mean?
Metagenomi Therapeutics (MGX) has a Float Percentage Of Total Shares Outstanding of 81.03% as of Jul. 05, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Metagenomi Therapeutics and its competitors.
Is Metagenomi Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Metagenomi Therapeutics' current Float Percentage Of Total Shares Outstanding is 81.03%. Overall, Metagenomi Therapeutics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Metagenomi Therapeutics' Float Percentage Of Total Shares Outstanding compare to KALA and HYPD?
Metagenomi Therapeutics' Float Percentage Of Total Shares Outstanding of 81.03% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Metagenomi Therapeutics and its competitors. Metagenomi Therapeutics's current Float Percentage Of Total Shares Outstanding is 81.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metagenomi Therapeutics stock overvalued right now?
Metagenomi Therapeutics (MGX) has a current Float Percentage Of Total Shares Outstanding of 81.03%. The current Float Percentage Of Total Shares Outstanding is 81.03%. Metagenomi Therapeutics' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Metagenomi Therapeutics (MGX), the current Float Percentage Of Total Shares Outstanding is 81.03% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metagenomi Therapeutics Business Description

Address 5959 Horton Street, 7th Floor, Emeryville, CA, USA, 94608
Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.
10GF Score

Get the complete analysis for MGX

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.26
Price